| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Bayer Aktiengesellschaft is a 10% Owner at Elanco Animal Health Inc with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $728.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2021 | IPSC Century Therapeutics, Inc. | 10% Owner | Buy | 750,000 | $20.00 | $15,000,000.00 | +6.3% | -16.0% | -63.8% | |
| Dec 3, 2020 | ELAN Elanco Animal Health Inc | 10% Owner | Sell | 54,500,000 | $29.84 | $1,626,367,200.00 | -74.7% | - | - | |
| Jan 5, 2018 | CRSP Crispr Therapeutics AG | 10% Owner | Buy | 527,472 | $22.75 | $11,999,988.00 | +10.3% | - | - |